Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 407 |
| Other current assets | 0 | 0 | 931 |
| TOTAL | $0 | $0 | $1,338 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 3,835 |
| Other Non-Current Assets | 0 | 0 | 60 |
| TOTAL | $N/A | $N/A | $3,895 |
| Total Assets | $0 | $0 | $4,340 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 1,673 |
| Accrued Expenses | 0 | 0 | 1,112 |
| TOTAL | $0 | $0 | $2,785 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 233 |
| TOTAL | $N/A | $N/A | $233 |
| Total Liabilities | $0 | $0 | $3,018 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 1 |
| Retained earnings | 0 | 0 | -35,536 |
| Other shareholders' equity | 0 | 0 | 34,587 |
| TOTAL | $0 | $0 | $1,322 |
| Total Liabilities And Equity | $0 | $0 | $4,340 |